FEDERAL APPEALS COURT REJECTS TRUMP REQUEST TO BLOCK

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks
202
FEDERAL APPEALS COURT REJECTS TRUMP REQUEST TO BLOCK CERTIFICATION OF PENNSLVANIA'S ELECTION RESULTS

By Jon Swaine
November 27, 2020 at 1:05 p.m. EST

A federal appeals court on Friday rejected President Trump’s request for an emergency injunction to overturn the certification of Pennsylvania’s election results.

The Third Circuit Court of Appeals said that the Trump campaign’s challenge of a U.S. district court’s decision had “no merit.”

The court’s sharply worded opinion was written by Judge Stephanos Bibas, who was appointed to the court by Trump.

“Charges of unfairness are serious. But calling an election unfair does not make it so. Charges require specific allegations and then proof. We have neither here,” Bibas wrote.

Trump’s campaign appealed after a district court last weekend dismissed its federal lawsuit against Pennsylvania election authorities and rejected its request to revise the suit.

Bibas noted in his decision on Friday that Trump’s campaign “never claims fraud or that any votes were cast by illegal voters,” and that granting Trump’s request to throw out the election results would be “grossly disproportionate.”

Jenna Ellis, a legal adviser to the Trump campaign, said in a tweet following the decision that the campaign would take its appeal to the Supreme Court.

“We are very thankful to have had the opportunity to present proof and the facts to the PA state legislature,” she wrote. “On to SCOTUS!”

https://www.washingtonpost.com/politics/feder...story.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Brixton Metals Expands Thorn Project with New Mineral Claims

Updated Category News Views 198

Brixton Metals Expands Thorn Project with New Mineral Claims Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) has expanded its footprint at the Thorn Project, securing a 100% interest in mineral claims covering 6,446 hectares. These claims, which were previously outside Brixton’s control, sit northwest of the well-known Golden Bear Mine and add ground the company...

Continue Reading
Nutex Health Awaits Q2 Results Amid Regulatory Hurdles

Updated Category News Views 20

Diving headfirst into the grumbles of this healthcare whirlwind we call Nutex Health. They've set the table to drop their Q2 financials on August 6, right after the bell, followed by a chat with investors the next morning. We're talking bumper-to-bumper business news here, and everyone with a slice in NASDAQ: NUTX better have their ears pricked. Nutex Health: A Mixed Bag...

Continue Reading
Arvore Partners LP Announces Impressive October Distribution

Updated Category News Views 183

Arvore Partners LP Declares Monthly Distribution for October Arvore Partners LP is thrilled to share details about the declaration of its monthly distribution for October. This distribution amounts to $687,365, which translates to an impressive 9.06% annualized yield for its unitholders, marking a 7% increase from the previous month. This consistent growth highlights...

Continue Reading
Key Insights on Marathon Petroleum's Upcoming Earnings Call

Updated Category News Views 101

An Overview of Marathon Petroleum's Earnings Expectations Marathon Petroleum (NYSE: MPC) is gearing up for its quarterly earnings announcement. Investors should prepare for necessary insights leading up to the release of this important announcement. Analysts predict a solid earnings per share (EPS) of $3.23 for the upcoming quarter. While it’s crucial for the company to...

Continue Reading
Revolutionizing Male Infertility Research with PacBio's Revio

Updated Category News Views 80

Transforming Male Infertility Research with PacBio's Revio MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading name in sequencing solutions, is launching an exciting collaboration with the University Hospital of Münster. This partnership is set to leverage long-read whole genome sequencing to significantly advance research in male infertility and rare diseases....

Continue Reading